COMMUNIQUÉS West-GlobeNewswire

GENFIT : Assemblée Générale Mixte du 15 juin 2026 — modalités de mise à disposition des documents préparatoires
11/05/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 11 mai 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares [...]
Lumenis Stellar M22™ with XPL Technology Named “Best New Dermatology Technology Solution” in 2026 MedTech Breakthrough Awards Program
11/05/2026
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
11/05/2026
Exercised options total USD 97 million, covering manufacturing of bulk vaccine and supply of freeze-dried vaccines. Company upgrades full-year financial guidance COPENHAGEN, Denmark, May 11, 2026 – Bavarian Nordic A/S ( [...]
Fagron shareholders approve all proposed resolutions at the General Meetings
11/05/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global player in [...]
IBA – ACQUISITION OF OWN SHARES
11/05/2026
Louvain-la-Neuve, Belgium, May 11 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA – ACQUISITION D’ACTIONS PROPRES
11/05/2026
Louvain-la-Neuve, Belgique, 11 mai 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
11/05/2026
ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI) , a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is excited [...]
Pheast Therapeutics Presents Preclinical Data on PHST677, a Novel Bispecific ADC Targeting CDH1 and Nectin-4 at PEGS Boston Summit 2026
11/05/2026
Preclinical data demonstrate a differentiated bispecific ADC design through E-cadherin blockade and Nectin-4 targeting REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Pheast Therapeutics , a clinical-stage [...]
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
11/05/2026
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief [...]
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
11/05/2026
Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the [...]
110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS
11/05/2026
CONSHOHOCKEN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- May is GBS|CIDP Awareness Month and this year marks 110 years since the discovery of Guillain-Barré syndrome (GBS), which was first identified and named in 1916 by [...]
Leo International Precision Health AG Plans Acquisitions of Nine Additional Assets in Asia and Europe to Accelerate the Commercialization of Its AI-Driven Portfolio Solutions
11/05/2026
Leo International Precision Health AG Plans Acquisitions of Nine Additional Assets in Asia and Europe to Accelerate the Commercialization of Its AI-Driven Portfolio Solutions Expected total transaction volume of EUR 400 [...]
Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure
11/05/2026
-Acoramidis increased sTTR early and significantly reduced intra-individual sTTR variability versus placebo (p<0.001), which is associated with reduced ACM, further reinforcing its differentiated profile in ATTR-CM - [...]
CONVENING NOTICE TO THE EXTRAORDINARY GENERAL MEETING 2026 OF IBA SA
11/05/2026
CONVENING NOTICE TO THE EXTRAORDINARY GENERAL MEETING 2026 OF IBA SA – WEDNESDAY JUNE 10, 2026, AT 11:00 A.M. – Dear Shareholder, We have the honor of convening you to the Extraordinary General Meeting (the " EGM ") of [...]
CONVOCATION À L’ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE DE IBA SA
11/05/2026
CONVOCATION À L’ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE DE IBA SA – MERCREDI 10 JUIN 2026, À 11H00 – Cher Actionnaire, Nous avons l’honneur de vous convoquer à une Assemblée Générale Extraordinaire d’IBA (l’ « AGE » ) au [...]
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
11/05/2026
HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized [...]
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
11/05/2026
Includes real-world clinical data from Biodesix researchers and independent Healthcare Professionals LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions [...]
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101
11/05/2026
Moderated discussion with Chief Scientific Officer Dr. Robert Pierce on ovarian cancer and evolving treatment landscape Segment highlights significant unmet need in ovarian cancer and the potential of ERNA-101 to [...]
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
11/05/2026
Strengthens Leadership Team and Board with additional business development, finance and royalty management expertise SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on [...]

Pages